A new study has identified what may be the first biomarker for chronic itch. Published in Drugs in Dermatology, researchers from the...

The U.S. Food and Drug Administration (FDA) has released an alert to healthcare professionals and consumers that unsafe counterfeit versions

There are significant delays in diagnosis and low implementation rates for treatment for HS.

Phase III studies of a personalized vaccine plus immunotherapy for melanoma have been launched at cancer centres around the world,...

“We thus expect that epigenetic causes are hidden not only in these but also in other diseases"

Topical melatonin and topical rosuvastatin were both effective in reducing the severity of mild-to-moderate plaque PsO.

“This [development] has the potential to transform how we diagnose and monitor concerning skin lesions and diseases in the clinic.”

Researchers have validated a novel scale for analyzing hyperpigmentation in a diverse U.S. population of varying skin tones.